High-Growth, Innovative Nutraceutical Opportunity

listing image
Gross Revenue:$11,028,987
EBITDA:$3,178,100
Inventory:$1,169,650
Established Year:2010
BUSINESS DESCRIPTION

Established Pharmaceutical Company: Portfolio of 12 well-branded, highly-recognizable products for children,
adults, and pets. Strong Financial Performance: Estimated to capture ~$10 million in annual revenue with an impressive 21% CAGR since 2020. Logistical Efficiency: Identified strategic logistical improvements poised to double net income.


DETAILED INFORMATION
Inventory
Not Included in asking price
Growth & Expansion
Retail Channel Expansion: Currently only selling online. Significantly grow sales by entering the huge, untapped specialty/natural and mass-market retail channels. Cost Optimization: Numerous opportunities to optimize costs and improve profitability.Pipeline for Growth: 3 newly released products expand the company’s offerings to capturing more of the $418 billion nutraceuticals market
Reason for Selling
Retirement
Report an Issue with this listing
profile-img
Jeff
Matre
logo-img
Jeff Matre